Best in Biotech 28 Jul 2022 Five companies personalizing treatments with 3D printed drugs …3D printing of ropinirole tablets for Parkinson’s disease. 3D inkjet printing deposits liquid materials or solid suspensions layer-by-layer but each deposited layer must first be dried, or “cured,” between the… July 28, 2022 - 5 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2023 10 immunotherapy companies making waves in 2023 …diseases like Parkinson’s. ElevateBio is looking to develop iPSC-derived therapies, for which it set up a new company in 2022, in a collaborative effort with Boston Children’s Hospital, where it… March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2020 Phase III Failure Sinks Drug for Rare Neurological Disorder …licensed from Merck KGaA after it failed phase III trials for Parkinson’s disease — had been billed as the first therapy to become independently commercialized by Newron. Adding to the… May 8, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 13 Sep 2022 WhiteLab Genomics raises $10M for AI-powered genomic therapies platform …4,000 human diseases including Alzheimer’s disease, Parkinson’s disease, cystic fibrosis, cardiovascular disease, Duchenne muscular dystrophy, and some types of cancer, originate from errors and changes in an individual’s DNA sequence…. September 13, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Jan 2020 10 Scientists Behind Modern Biotech You Probably Don’t Know …treatments for sickle-cell anemia and Parkinson’s disease using these cells. Françoise Barré-Sinoussi (born 1947) Francois Barre-Sinoussi, 2012 – International AIDS Conference in Washington DC. Photo credit: Michael Fleshman Françoise Barré-Sinoussi… January 28, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 We DUB this target ‘druggable’ …cellular health and longevity. Recently presented at the 2022 Society for Neuroscience (SfN) conference, new data from the Beth Israel Deaconess Medical Center (BIDMC) cements Parkinson’s disease (PD) as a… January 11, 2023 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2025 Deal after deal: Novartis spends billions in 2025 …of alpha-synuclein protein in the brain. This includes conditions like Parkinson’s disease, where alpha-synuclein buildup is a hallmark of the disease. Novartis has bagged the worldwide license for its preclinical siRNA… October 22, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Apr 2024 Chicago biotech: Seven players advancing the industry …diseases. Their lead program is VQ-101, a small molecule designed to activate glucocerebrosidase (GCase), particularly targeting Parkinson’s disease (PD) and Dementia with Lewy Bodies (DLB), a type of progressive dementia… April 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Aug 2024 Seven companies transforming the biotech industry in Italy …such as certain cancers and neurodegenerative diseases like Huntington’s and Parkinson’s. The Italian biotech’s pipeline includes several FID-based candidates targeting various therapeutic areas but its pipeline is still preclinical. Its… August 22, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Oct 2022 15 biotech companies shaking up the scene in Cambridge …and Parkinson’s disease. The company currently has six programs in its pipeline, four in-house programs in research and preclinical phases and two undisclosed partnered programs with AbbVie and Pfizer. Last… October 6, 2022 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 29 May 2018 Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done? …mental illnesses as well as neurodegenerative disorders such as Parkinson’s and Alzheimer’s. Closely linked with the microbiome is research into metabolism. “This is not yet an area sufficiently mainstream, but… May 29, 2018 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 10 May 2019 This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins …on the case, discovering new leads that could degrade proteins involved in Alzheimer’s and Parkinson’s disease. Sandham told me that Polyprox could enter the neurodegenerative disease space with a potential… May 10, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email